SCHEMBL11955243

SCHEMBL11955243

COc1ccc(O)c(C(C)(C)C)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 4/20 0.39
TDP1 Q9NUW8 2/20 0.38
POLB P06746 2/20 0.38
NNMT P40261 3/20 0.37
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
ALDH1A1 P00352 3/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
LMNA P02545 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
KMT2A Q03164 1/20 0.33
TP53 P04637 1/20 0.33
ERN1 O75460 1/20 0.33
CYP2C9 P11712 2/20 0.32
NR1I2 O75469 1/20 0.32
MIF P14174 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21055249 0.82 TSHR (0.39) TDP1POLBNNMTHSD17B10CYP1A2
SCHEMBL22949459 0.78 CA1 (0.36) ALOX15TDP1POLBNNMTCA1
SCHEMBL21719170 0.76 HPGD (0.36) TDP1POLBNNMTALDH1A1HPGD
SCHEMBL22570331 0.76 POLB (0.34) TDP1POLBNNMTCYP1A2SIRT2
SCHEMBL21719172 0.76 POLB (0.34) TDP1POLBNNMTALDH1A1CYP1A2
SCHEMBL29091456 0.74 POLB (0.42) ALOX15TDP1POLBNNMTCA1
SCHEMBL28935930 0.74 POLB (0.42) ALOX15TDP1POLBNNMTCA1
SCHEMBL22962910 0.73 TXNRD1 (0.36) TDP1POLBNNMTCYP1A2SIRT2
SCHEMBL11954928 0.72 ALDH1A1 (0.47) ALOX15TDP1ALDH1A1HPGDHSD17B10
SCHEMBL586103 0.72 NNMT (0.53) TDP1POLBNNMTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895580-B2 Quinolinone-pyrazolone M1 receptor positive allosteric modulators MERCK SHARP & DOHME CORP. (US) 2014-11-25 US disclosed
US-20120196845-A1 QUINOLINONE-PYRAZOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME LLC 2012-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196845-A1 QUINOLINONE-PYRAZOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS CHRM1, OPRL1, CHRNA5 ALOX15 1865/4885TDP1 2391/4885POLB 3551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.